We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for clinicians and patients.
Information for patients, public and health care professionals.
This article will expand on the existing analysis published in the fortnightly Winter Coronavirus (COVID-19) Infection Study data tables to look more in depth at trends in self-reported symptoms of COVID-19, including ongoing symptoms and associated risk factors.
Guidance on symptoms of Zika virus infection and complications of the disease.
The symptoms and epidemiology of giardiasis including travel-associated infections.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (30 January 2024) approved the medicine momelotinib (Omjjara) to treat the symptoms experienced by adult myelofibrosis patients who have moderate or severe anaemia (a low number of red blood cells...
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Advice for health professionals on tick-borne encephalitis (TBE) including symptoms, diagnosis and epidemiology.
If your company is in difficulty, it's important to maintain good mental health.
Travel and clinical advice on Cyclospora including characteristics, symptoms, diagnosis and epidemiology.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Globally, there has been a very small number of reports of new-onset or aggravation of pre-existing myasthenia gravis with atorvastatin, pravastatin, lovastatin, fluvastatin, simvastatin, rosuvastatin and pitavastatin (single-ingredient and fixed-dose combination products). Advise patients taking statins to be alert to...
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Information for clinicians on the characteristics, diagnosis and epidemiology of infections caused by Chlamydia psittaci.
Guillain-Barré syndrome is a rare neurological condition which can occur following Zika virus infection.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.